View in EDS HTML Full Text PDF Full Text

Nanopore sequencing as a cutting-edge technology for medulloblastoma classification.

Saved in:
Bibliographic Details
Title: Nanopore sequencing as a cutting-edge technology for medulloblastoma classification.
Authors: Filser M; PSL Research University, Paris, France.; Genetics Department, Institut Curie, Paris, France., Torrejon J; Université Paris-Saclay, CNRS UMR 3347, INSERM U1021, Orsay, France.; PSL Research University, Paris, France., Merchadou K; Bioinformatics Clinic Unit, Institut Curie, Paris, France., Dufour C; Department of Pediatric and Adolescent Oncology, Institut Gustave-Roussy, Villejuif, France., Girard E; INSERM U900, Institut Curie, Paris, France.; PSL Research University, Paris, France., Bourneix C; PSL Research University, Paris, France.; Genetics Department, Institut Curie, Paris, France., Lemaître E; PSL Research University, Paris, France.; Genetics Department, Institut Curie, Paris, France., Gharsalli T; Université Paris-Saclay, CNRS UMR 3347, INSERM U1021, Orsay, France.; PSL Research University, Paris, France., Brillet R; INSERM U900, Institut Curie, Paris, France.; PSL Research University, Paris, France., Wong J; PSL Research University, Paris, France.; Genetics Department, Institut Curie, Paris, France., Gentien D; Institut Curie, PSL Research University, Translational Research Department, Genomics Platform, Paris, France., Rapinat A; Institut Curie, PSL Research University, Translational Research Department, Genomics Platform, Paris, France., Servant N; INSERM U900, Institut Curie, Paris, France.; PSL Research University, Paris, France., Vasiljevic A; ONCOFLAM - Neuro-Oncologie et Neuro-Inflammation Centre de Recherche en Neurosciences de Lyon, Lyon, France.; Centre de Pathologie et Neuropathologie Est, Centre de Biologie et Pathologie Est, Groupement Hospitalier Est, Hospices Civils de Lyon, Bron, France., Bertozzi AI; Pediatric Oncology Department, Children's Hospital, Toulouse University Hospital, Toulouse, France., Raimbault S; Department of Pediatric Oncology, Oscar Lambret Cancer Center, Lille, France., Tauziede Espariat A; Neuropathology Unit, GHU Paris Psychiatry and Neurosciences, Sainte-Anne Hospital, Paris University, Paris, France., Lhermitte B; Department of Pathology, Strasbourg University Hospital, Strasbourg, France., Faure-Conter C; Department of Pediatric Oncology, Institut d'Hemato-oncologie Pediatrique, Lyon, France., Icher C; Department of Pediatric Onco-Hematology, University Hospital, Bordeaux, France., Berger C; Department of Paediatric Haematology and Oncology, University Jean Monnet, University-Hospital of Saint-Etienne, Saint-Etienne, France., Maurage CA; Department of Pathology, Centre Biologie Pathologie, Lille University Hospital, Hopital Nord, Lille, France., Bodet D; Department of Pediatric Hematology and Oncology, University Hospital of Caen, Caen, France., Meyronet D; University Claude Bernard Lyon I, Villeurbanne, France.; Department of Neuropathology, East Hospital Group, Hospices Civils de Lyon, Bron, France., Uro-Coste E; Department of Anatomy and Pathologic Cytology, Faculté de Santé, Institut Universitaire du Cancer Toulouse - Oncopole, Université Toulouse III Paul-Sabatier, Toulouse, France., De Carli E; Department of Pediatric Oncology, University Hospital, Angers, France., Forest F; Departments of Pathology and Molecular Biology of Tumors, University Hospital of Saint Etienne, Saint Etienne, France., Palenzuela G; Department of Pediatric Hematology-Oncology, Centre Hospitalo-Universitaire de Montpellier, Montpellier, France., Chotard G; Department of Pathology, Pellegrin Hospital, Bordeaux, France., Gauchotte G; INSERM U1256 NGERE, Université de Lorraine, Vandœuvre-lès-Nancy, France.; Department of Biopathology CHRU of Nancy, Institut de Cancérologie de Lorraine, CHRU Nancy, Université de Lorraine, Vandœuvre-lès-Nancy, France., Sudour H; Pediatric and Young Adults Oncology Department, Centre Oscar Lambret, Lille, France., Mansuy L; French Cancer Society (SFCE), Bordeaux, France.; Department of Pediatric Hematology and Oncology, Nancy University Hospital, Vandœuvre-lès-Nancy, France., Deparis M; CHU, Department of Pediatric Oncology and Hematology, Caen, France., Tallegas M; Department of Pathology, Université de Tours, Centre Hospitalier Universitaire de Tours, Tours, France., Faisant M; Department of Pathology, CHU de Caen, Caen, France., Entz-Werle N; Team OnKO-3T, Laboratory of Bioimaging and Pathologies, University of Strasbourg, Strasbourg, France.; Pediatric Onco-Hematology Unit, University Hospital of Strasbourg, Strasbourg, France., Varlet P; Neuropathology Unit, GHU Paris Psychiatry and Neurosciences, Sainte-Anne Hospital, Paris University, Paris, France., Leblond P; Oscar Lambret Comprehensive Cancer Center, Pediatric Oncology Unit, Lille, France.; Centre Léon Bérard, IHOPe, Lyon, France.; Department of Pediatric Oncology, Institut d'Hemato-oncologie Pediatrique, Lyon, France., Michalak-Provost S; Angers University Hospital, Department of Pathology, Angers, France., Proust Houdemont S; Department of Pediatric Onco-Hemato-Immunology, CHU Angers, Angers, France., Rigau V; Institute of Functional Genomics, Montpellier University CNRS, INSERM U1191, Montpellier, France.; Department of Pathology and Onco-biology, Gui de Chauliac University Hospital, Montpellier, France., Doz F; Paris Cité University, Paris, France.; SIREDO Pediatric Centre (Care, Innovation, Research in Pediatric, Adolescent and Young Adult Oncology), Institut Curie, Paris, France., Delattre O; INSERM U830, Laboratory of Translational Research in Pediatric Oncology, Paris, France.; SIREDO Pediatric Centre (Care, Innovation, Research in Pediatric, Adolescent and Young Adult Oncology), Institut Curie, Paris, France.; Genetics Department, Institut Curie, Paris, France., Bourdeaut F; Paris Cité University, Paris, France.; INSERM U830, Laboratory of Translational Research in Pediatric Oncology, Paris, France.; SIREDO Pediatric Centre (Care, Innovation, Research in Pediatric, Adolescent and Young Adult Oncology), Institut Curie, Paris, France., Ayrault O; Université Paris-Saclay, CNRS UMR 3347, INSERM U1021, Orsay, France.; PSL Research University, Paris, France., Masliah-Planchon J; INSERM U830, Laboratory of Translational Research in Pediatric Oncology, Paris, France.; PSL Research University, Paris, France.; Genetics Department, Institut Curie, Paris, France.
Source: Neuro-oncology [Neuro Oncol] 2025 Jun 21; Vol. 27 (5), pp. 1313-1324.
Publication Type: Journal Article
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print Cited Medium: Internet ISSN: 1523-5866 (Electronic) Linking ISSN: 15228517 NLM ISO Abbreviation: Neuro Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1523-5866
DOI:10.1093/neuonc/noae279